Sep 11, 2023 / 11:00AM GMT
Emily Bodnar - H.C. Wainwright & Co., LLC - Analyst
(audio in progress) for joining the H.C. Wainwright 25th Annual Global Investment Conference taking place on September 11 through 13, both virtually and in person. My name is Emily Bodnar, and I'm an equity research analyst at H.C. Wainwright.
I'm pleased to introduce our next presenter, Erik Manting, who is the Chief Executive Officer of Mendus.
Erik Manting - Mendus AB(publ)-CEO
Thank you, Emily. So today, let me guide you through why we are dedicated to changing the course of cancer treatment.
Mendus is a listed company on the Stockholm Nasdaq Stock Exchange. Disclaimer, of course, can also be found on our website.
We are pioneering cancer maintenance therapy, and what we mean with that is we believe that the biggest impact in today's cancer therapy landscape can be made by keeping patients longer in a healthy state after their initial treatment. In quite a lot of tumors, the recurrence of the tumor or the relapse of the disease is the main
Mendus AB (publ) at HC Wainwright Investment Conference - New York Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot